Mike Harik

420 total citations
12 papers, 304 citations indexed

About

Mike Harik is a scholar working on Urology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Mike Harik has authored 12 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Urology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Rheumatology. Recurrent topics in Mike Harik's work include Urinary Bladder and Prostate Research (7 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Pelvic floor disorders treatments (3 papers). Mike Harik is often cited by papers focused on Urinary Bladder and Prostate Research (7 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Pelvic floor disorders treatments (3 papers). Mike Harik collaborates with scholars based in Austria, United Kingdom and Hungary. Mike Harik's co-authors include Bob Djavan, Michael Marberger, Matthias Waldert, Yan Kit Fong, Theodore Anagnostou, Christian Seitz, Mesut Remzi, Michael Dobrovits, Andreas Reissigl and Fariborz Bagheri and has published in prestigious journals such as The Journal of Urology, Urology and World Journal of Urology.

In The Last Decade

Mike Harik

11 papers receiving 288 citations

Peers

Mike Harik
Hyun Hwan Sung South Korea
K J Hoefner United States
Susan Foller Germany
Taghreed Almahmeed United States
E. Mandron France
Carlos Muñoz-López United States
Elenko Popov Bulgaria
C. K. McSherry United States
Zoe Michael United States
Hyun Hwan Sung South Korea
Mike Harik
Citations per year, relative to Mike Harik Mike Harik (= 1×) peers Hyun Hwan Sung

Countries citing papers authored by Mike Harik

Since Specialization
Citations

This map shows the geographic impact of Mike Harik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Harik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Harik more than expected).

Fields of papers citing papers by Mike Harik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike Harik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Harik. The network helps show where Mike Harik may publish in the future.

Co-authorship network of co-authors of Mike Harik

This figure shows the co-authorship network connecting the top 25 collaborators of Mike Harik. A scholar is included among the top collaborators of Mike Harik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike Harik. Mike Harik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Bagó-Horváth, Zsuzsanna, Philipp Saiko, Michael Grusch, et al.. (2007). Novel resveratrol derivatives induce apoptosis and cause cell cycle arrest in prostate cancer cell lines.. PubMed. 27(5A). 3459–64. 39 indexed citations
2.
Harik, Mike, Matthias Waldert, Bob Djavan, et al.. (2006). EIGHT-YEAR MULTICENTRE EUROPEAN POOLED ANALYSIS OF CLINICAL AND URODYNAMIC OUTCOME AND RETREATMENT RATES OF HIGH-ENERGY TRANSURETHRAL MICROWAVE THERMOTHERAPY:. European Urology Supplements. 5(2). 233–233. 1 indexed citations
3.
Djavan, Bob, Yan Kit Fong, Andreas Reissigl, et al.. (2005). Progression delay in men with mild symptoms of bladder outlet obstruction: a comparative study of phytotherapy and watchful waiting. World Journal of Urology. 23(4). 253–256. 14 indexed citations
4.
Harik, Mike, et al.. (2005). Dutasteride: a review of current data on a novel dual inhibitor of 5alpha reductase.. PubMed. 7(4). 203–10. 33 indexed citations
5.
Remzi, Mesut, Yan Kit Fong, Michael Dobrovits, et al.. (2005). THE VIENNA NOMOGRAM: VALIDATION OF A NOVEL BIOPSY STRATEGY DEFINING THE OPTIMAL NUMBER OF CORES BASED ON PATIENT AGE AND TOTAL PROSTATE VOLUME. The Journal of Urology. 174(4 Part 1). 1256–1261. 105 indexed citations
6.
Djavan, Bob, Yan Kit Fong, Mike Harik, et al.. (2004). Longitudinal study of men with mild symptoms of bladder outlet obstruction treated with watchful waiting for four years. Urology. 64(6). 1144–1148. 70 indexed citations
7.
Dobrovits, Michael, Matthias Waldert, Bob Djavan, et al.. (2004). 148 Artificial neural networks to predict progression in men with mild symptoms of bladder outlet obstruction (BOO) under watchful waiting for 5 years. European Urology Supplements. 3(2). 39–39. 1 indexed citations
8.
Fong, Yan Kit, et al.. (2004). Preventing progression in men with mild symptoms of benign prostatic hyperplasia: a potential role for phytotherapy.. PubMed. 6(4). 187–92.
9.
10.
Dobrovits, Michael, et al.. (2003). A longitudinal prospective study of men with mild symptoms of BOO treated with watchfull waiting over 4 years. European Urology Supplements. 2(1). 26–26. 8 indexed citations
11.
Djavan, Bob, Alexandre R. Zlotta, Mike Harik, et al.. (2002). Predictors of progression in men with mild sypmtoms of bladder outlet obstruction. European Urology Supplements. 1(1). 50–50. 1 indexed citations
12.
Djavan, Bob, Christian Seitz, Claus G. Roehrborn, et al.. (2001). Targeted transurethral microwave thermotherapy versus alpha-blockade in benign prostatic hyperplasia: outcomes at 18 months. Urology. 57(1). 66–70. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026